2,300
Participants
Start Date
March 3, 2014
Primary Completion Date
October 17, 2017
Study Completion Date
October 17, 2017
Tacrolimus
oral
Site IE35301, Dublin
Site BE32002, Brussels
Site HU36001, Budapest
Site AT43002, Vienna
Site BE32007, Brussels
Site BE32003, Leuven
Site BE32005, Leuven
Site CH41002, Bern
Site BE32008, Liège
Site BE32009, Liège
Site AT43003, Linz
Site HU36003, Debrecen
Site FR33015, Nice
Site AT43001, Innsbruck
Site DE49014, Halle
Site HU36002, Szeged
Site ES34012, Badalona-Barcelona
Site BE32001, Ghent
Site DE49004, Berlin
Site FR33011, Marseille
Site ES34010, Córdoba
Site SE46002, Stockholm
Site ES34005, A Coruña
Site IT39006, Genova
Site DE49017, Rostock
Site IT39012, Milan
Site IT39009, Milan
Site FR33032, Dijon
Site RO40001, Bucharest
Site RO40003, Bucharest
Site DE49002, Kiel
Site IT39003, Bergamo
Site FR33007, Besançon
Site ES34006, Madrid
Site ES34013, Madrid
Site ES34015, Madrid
Site FR33025, Brest
Site DE49005, Hanover
Site DE49018, Hanover
Site IT39021, Treviso
Site FR33034, Toulouse
Site FR33012, Bordeaux
Site IT39001, Udine
Site FR33014, Montpellier
Site DE49022, Hannoversch Münden
Site IT39002, Padua
Site IT39010, Padua
Site IT39011, Vicenza
Site FR33009, Tours
Site FR33030, Tours
Site ES34009, Santa Cruz de Tenerife
Site ES34020, Santander
Site IT39005, Bologna
Site IT39013, Bologna
Site DE49013, Düsseldorf
Site ES34014, Seville
Site SE46001, Gothenburg
Site FR33022, Saint-Etienne
Site FR33023, Nantes
Site DE49019, Bochum
Site DE49030, Essen
Site ES34021, Valencia
Site ES34016, Valladolid
Site ES34019, Barakaldo
Site FR33020, Angers
Site ES34007, Zaragoza
Site EE37201, Tartu
Site DE49011, Aachen
Site IT39019, Siena
Site FR33028, Vandœuvre-lès-Nancy
Site IT39015, Ancona
Site DE49001, Frankfurt am Main
Site FR33027, Clermont-Ferrand
Site CZ42006, Brno
Site FR33017, Strasbourg
Site IT39014, L’Aquila
Site DE49015, Kaiserslautern
Site DE49027, Mannheim
Site CZ42005, Ostrava
Site DE49006, Tübingen
Site SE46004, Uppsala
Site FR33008, Paris
Site FR33010, Paris
Site FR33031, Paris
Site FR33019, Paris
Site FR33024, Rouen
Site IT39008, Naples
Site PL48003, Gdansk
Site DE49025, Munich
Site DE49016, Munich
Site IT39017, Salerno
Site FR33018, Limoges
Site IT39016, Palermo
Site FR33003, Clichy, Paris
Site DE49010, Regensburg
Site FR33001, Créteil
Site FR33029, Créteil
Site FR33026, Le Kremlin-Bicêtre
Site FR33002, Villejuif
Site RU70005, Moscow
Site RU70002, Moscow
Site RU70004, Moscow
Site RU70007, Moscow
Site BY37501, Minsk
Site RU70011, Volzhskiy
Site RU70013, Volzhskiy
Site RU70012, Yekaterinburg
Site RU70010, Omsk
Site RU70014, Kemerovo
Site CA15001, Halifax
Site CA15003, Montreal
Site CZ42004, Hradec Králové
Site CZ42003, Olomouc
Site CZ42001, Prague
Site CZ42002, Prague
Site FI35801, Helsinki
Site FI35802, Helsinki
Site FR33004, Nice
Site DE49008, Jena
Site IT39004, Rome
Site IT39020, Rome
Site LV37101, Riga
Site NL31001, Maastricht
Site PL48006, Katowice
Site PL48005, Lodz
Site PL48007, Poznan
Site PL48004, Szczecin
Site PL48001, Warsaw
Site PT35102, Lisbon
Site SK42101, Banská Bystrica
Site SK42102, Bratislava
Site KR82007, Busan
Site KR82006, Daegu
Site KR82002, Seoul
Site KR82005, Seoul
Site KR82001, Seoul
Site ES34001, L'Hospitalet de Llobregat
Site ES34018, L'Hospitalet de Llobregat
Site ES34017, Alicante
Site ES34004, Barcelona
Site ES34011, Barcelona
Site ES34003, Barcelona
Site GB44001, Birmingham
Site GB44003, Leeds
Site GB44002, London
Astellas Pharma Europe Ltd.
INDUSTRY